Adherence in the management of arterial hypertension in patients of the subsidized regime. Barranquilla, Colombia.
Keywords:
Hypertension, Treatment Adherence and ComplianceAbstract
Objective
To establish adherence to treatment for the management of arterial hypertension in patients of the subsidized regimen in the District of Barranquilla - Colombia.
Methods
Descriptive, analytical cross-sectional study, with application of the CAT-HTA of Varela 2010. The sample was made up of 400 individuals from the cardiovascular risk program of the subsidized regime in Barranquilla. The analysis was performed with STATGRAPHIC Centurión 18 and the R statistic.
Results
76% of the sample were female, with an average age of 63.52 years, and an average evolution time of 9.59 years. The degree of adherence according to Varela was 32%. There is no evidence of statistical significance between the sociodemographic characteristics and the degree of adherence.
Conclusion/Final considerations
Adherence in the study population was not optimal. Understanding and managing the factors that determine adherence can help strengthen monitoring programs for hypertensive patients.
Downloads
References
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020
International society of hypertension global hypertension practice guidelines. J
Hypertens. 2020;38(6):982–1004.
Bromfield S, Muntner P. High blood pressure: The leading global burden of disease
risk factor and the need for worldwide prevention programs. Curr Hypertens Rep.
;15(3):134–6.
Diez principales causas de muerte [Internet]. Organización Mundial de la Salud.
[citado 16 junio 2021]. Disponible en: https://www.who.int/en/news-room/factsheets/detail/the-top-10-causes-of-death
Enfermedades cardiovasculares [Internet]. Organización Mundial de la Salud. 2017
[citado 16 junio 2021]. Disponible en: https://www.who.int/en/news-room/factsheets/detail/cardiovascular-diseases-(cvds)
Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to
action and a lifecourse strategy to address the global burden of raised blood pressure
on current and future generations: the Lancet Commission on hypertension. Lancet.
;388(10060):2665–712.
Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, et al. Systolic blood pressure
reduction and risk of cardiovascular disease and mortality a systematic review and
network meta-analysis. JAMA Cardiol. 2017;2(7):775–81.
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood
pressure lowering for prevention of cardiovascular disease and death: A systematic
review and meta-analysis. Lancet [Internet]. 2016;387(10022):957–67. Available from:
http://dx.doi.org/10.1016/S0140-6736(15)01225-8
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood
pressure lowering for prevention of cardiovascular disease and death: A systematic
review and meta-analysis. Lancet [Internet]. 2016;387(10022):957–67. Available from:
http://dx.doi.org/10.1016/S0140-6736(15)01225-8
Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto costo (CAC).
Situación de la Enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus
en Colombia; Bogotá D.C. 2021
Guideline for the pharmacological treatment of hypertension in adults. Geneva: World
Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO
Visaria A, Lo D. Association between body mass index and hypertension subtypes
in Indian and United States adults. Indian Heart J [Internet]. 2020;72(5):459–61.
Available from: https://doi.org/10.1016/j.ihj.2020.08.009
Niklas A, Marcinkowska J, Kozela M, Pająk A, Zdrojewski T, Drygas W, et al. Prevalence
of cardiometabolic risk factors and selected cardiovascular diseases in hypertensive
and normotensive participants in the adult Polish population: The WOBASZ II study.
Medicine (Baltimore). 2020;99(28):e21149.
Plante TB, Koh I, Judd SE, Howard G, Howard VJ, Zakai NA, et al. Life’s simple 7 and
incident hypertension: The regards study. J Am Heart Assoc. 2020;9(19)
Hinderliter AL, Smith P, Sherwood A, Blumenthal J. Lifestyle Interventions Reduce
the Need for Guideline-Directed Antihypertensive Medication. American Journal
of Hypertension [Internet]. 2021 [citado 22 diciembre 2021];34(10):11001107.
Disponible en: https://doi.org/10.1093/ajh/hpab090
Hinderliter AL, Sherwood A, Craighead LW, Lin PH, Watkins L, Babyak MA, et al.
The long-term effects of lifestyle change on blood pressure: One-year follow-up of
the ENCORE study. Am J Hypertens. 2014;27(5):734–41 Disponible en: https://doi.
org/10.1093/ajh/hpt183
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, Zhu L, Hu F, Li X, Meng S, Yan R, Zhao
S, Onwuka JU, Yang B, Sun D, Zhao Y. Nonpharmacologic Interventions for Reducing
Blood Pressure in Adults with Prehypertension to Established Hypertension. J Am
Heart Assoc. 2020 Oct 20;9(19): e016804. doi: 10.1161/JAHA.120.016804.
Battista F, Ermolao A, van Baak MA, Beaulieu K, Blundell JE, Busetto L, et al. Effect
of exercise on cardiometabolic health of adults with overweight or obesity: Focus
on blood pressure, insulin resistance, and intrahepatic fat—A systematic review and
meta-analysis. Obes Rev. 2021;22(S4):1–15.
Iellamo F, Caminiti G, Montano M, Manzi V, Franchini A, Mancuso A, et al. Prolonged
post-exercise hypotension: Effects of different exercise modalities and training statuses
in elderly patients with hypertension. Int J Environ Res Public Health. 2021;18(6):1–
Verma N, Rastogi S, Chia YC, Siddique S, Turana Y, Cheng H min, et al. Nonpharmacological management of hypertension. J Clin Hypertens. 2021;23(7):1275–83
Korhonen MJ, Penti J, Hartikainen J, Ilomäki J, Setoguchi S, Kivimäki M, Vahtera J.
Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering
Medication: A Cohort Study. J Am Heart Assoc. 2020 Feb 5;9: e014168. https://doi.
org/10.1161/JAHA.119.014168
Oliveros E, Patel H, Kyung S, Fugar S, Goldberg A, Madan N, et al. Hypertension in
older adults: assessment, management, and challenges. Clin Cardiol. (2020) 43:99–
doi: 10.1002/clc.23303
Ozemek C, Tiwari S, Sabbahi A, Carbone S, Lavie CJ. Impact of therapeutic lifestyle
changes in resistant hypertension. Prog Cardiovasc Dis. 2020;63(1):4–9. https://doi.
org/10.1016/j.pcad.2019.11.012
Sabbahi, A., Severin, R., Laddu, D. et al. Nonpharmacological Management of Resistant
Hypertension. Curr Cardiol Rep 23, 166 (2021). https://doi.org/10.1007/s11886-021-
-4
Haynes RB. Determinants of compliance: The disease and the mechanics of treatment.
Baltimore MD, Johns Hopkins University Press, 1979.
Rand C.S. Measuring adherence with therapy for chronic diseases: implications for
the treatment of heterozygous familial hypercholesterolemia, Am J Cardiol. 1993; 72:
D-74D
Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo:
Pruebas para la acción. Ginebra: Organización Panamericana de la Salud. 2004
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–
doi: 10.1056/NEJMra050100
Enfermedades cardiovasculares [Internet]. Organización mundial de la salud. 2021
[citado 19 junio 2021]. Disponible en: https://www.who.int/en/news-room/factsheets/detail/cardiovascular-diseases-(cvds)
Lancet T. Hypertension: An urgent need for global control and prevention. Lancet
[Internet]. 2014;383(9932):1861. Available from: http://dx.doi.org/10.1016/S0140-
(14)60898-9
Hypertension Need Not Be A “Silent Killer” [Internet]. Word Heart Federation. 2021
[citado 18 junio 2021]. Disponible en: https://world-heart-federation.org/news/
hypertension-need-not-be-a-silent-killer/
Varela, MT. Manual de aplicación, calificación e interpretación del Cuestionario de
adherencia al tratamiento para la hipertensión arterial (CAT-HTA) [Documento no
publicado]: Bogotá: Pontificia Universidad Javeriana Cali, 2010
Varela MT. El reto de evaluar la adherencia al tratamiento en la hipertensión arterial.
Revista Pensamiento Psicológico, 2010;7(14),127-140.
López-Romero LA, Romero-Guevara SL, et al. Adherencia Al Tratamiento: Concepto
Y Medición. Hacia la promoción la salud. 2016;0121–7577(2462–8425):117–37
CP BI. Design of an instrument to evaluate the factors influencing the treatment adherence in people with cardiovascular disease risks. Av en Enferm [Internet]. 2007;25(1):46–55. Available from: http://search.ebscohost.com.accedys2.bbtk.ull.es/login.aspx?direct=true&db=ccm&AN=105338447&lang=es&site=ehost-live.
Alfonso LM, Bayarre Vea H, Coruego Rodrígues M del C, Vento Iznaga F, La Rosa Matos Y, Orbay Araña M de la C. Adherencia al tratamiento en hipertensos atendidos en áreas de salud de tres provincias cubanas Adherence to treatment observed in hypertensive patients from health areas of three Cuban provinces. Rev Cuba Salud Pública [Internet]. 2015;41(1):33–45. Available from: http://scielo.sld.cu
Olivella Fernandez M, Bastidas Sanchez CV, Bonilla Ibañez CP. Comportamientos de autocuidado y adherencia terapéutica en personas con enfermedad coronaria que reciben atención en una institución hospitalaria de Ibagué, Colombia. Investig en Enfermería Imagen y Desarro. 2016;18(2):13.
Jankowska-Polańska B, Chudiak A, Uchmanowicz I, Dudek K, Mazur G. Selected factors affecting adherence in the pharmacological treatment of arterial hypertension. Patient Prefer Adherence. 2017;11:363–71
Biffi A, Rea F, Iannaccone T, Filippelli A, Mancia G, Corrao G. Sex differences in the adherence of antihypertensive drugs: A systematic review with meta-analyses. BMJ Open. 2020;10(7).
Paczkowska A, Hoffmann K, Kus K, Kopciuch D, Zaprutko T, Ratajczak P, et al. Impact of patient knowledge on hypertension treatment adherence and efficacy: A singlecentre study in poland. Int J Med Sci. 2021;18(3):852–60.
Zambrano C R, Duitama M J, Posada V J, Flórez A J. Percepción de la adherencia a tratamientos en pacientes con factores de riesgo cardiovascular. Rev Fac Nac Salud Pública. 2012;30(2):163–74.
Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK, Morisky DE. Adherence to Antihypertensive Medications: Population Based Follow up in Eastern Nepal. J Nepal Health Res Counc. 2015 Jan-Apr;13(29):38-42. PMID: 26411711
Parra DI, Romero Guevara SL, Rojas LZ. Influential factors in adherence to the therapeutic regime in hypertension and diabetes. Investig y Educ en Enferm. 2019;37(3). Castaño-Castrillón JJ, Echeverri-Rubio C, Giraldo-Cardona JF, Maldonado-Mora Á, Melo-Parra J, Meza-Orozco GA, et al. Adherencia al tratamiento de pacientes hipertensos atendidos en Assbasalud E.S.E, Manizales (Colombia) 2011. Rev. Fac. Med. 2012; 60(3):179-97.
